Pharmacological targeting of cognitive impairment in depression: recent developments and challenges...
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Impaired cognition is often overlooked in the clinical management of depression, despite its association with poor psychosocial functioning and reduced clinical engagement. There is an outstanding need for new treatments to address this unmet clinical need, highlighted by our consultations with individuals with lived experience of depression. Here...
Alternative Titles
Full title
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c95d063c6a8144c9893ced8886105901
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c95d063c6a8144c9893ced8886105901
Other Identifiers
ISSN
2158-3188
E-ISSN
2158-3188
DOI
10.1038/s41398-022-02249-6
